Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 381 (9863), 333-42

Noonan Syndrome

Affiliations
Review

Noonan Syndrome

Amy E Roberts et al. Lancet.

Abstract

Noonan syndrome is a genetic multisystem disorder characterised by distinctive facial features, developmental delay, learning difficulties, short stature, congenital heart disease, renal anomalies, lymphatic malformations, and bleeding difficulties. Mutations that cause Noonan syndrome alter genes encoding proteins with roles in the RAS-MAPK pathway, leading to pathway dysregulation. Management guidelines have been developed. Several clinically relevant genotype-phenotype correlations aid risk assessment and patient management. Increased understanding of the pathophysiology of the disease could help development of pharmacogenetic treatments.

Conflict of interest statement

Conflicts of interest

BDG and MT have received royalties for genetic testing for Noonan syndrome from the following: GeneDx, Prevention Genetics, Correlagen, Harvard/Partners, and Baylor College of Medicine. AER and JEA declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1. The RAS–MAPK signaling pathway
Growth signals are relayed from activated growth factor receptors to the nucleus. Mutations in PTPN11, KRAS, SOS, NRAS, and RAF1 are associated with Noonan syndrome and mutations in SHOC2 and CBL are associated with a Noonan syndrome-like phenotype.
Figure 2
Figure 2. Five generations of a family with Noonan syndrome caused by an SOS1 mutation
Distinguishing facial features become milder with age.

Similar articles

  • Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines
    AA Romano et al. Pediatrics 126 (4), 746-59. PMID 20876176. - Review
    Noonan syndrome (NS) is a common, clinically and genetically heterogeneous condition characterized by distinctive facial features, short stature, chest deformity, congeni …
  • [Noonan Syndrome Can Be Diagnosed Clinically and Through Molecular Genetic Analyses]
    MK Henningsen et al. Ugeskr Laeger 177 (32), V12140755. PMID 26321587. - Review
    Noonan syndrome is part of the group of RASopathies caused by germ line mutations in genes involved in the RAS/MAPK pathway. There is substantial phenotypic overlap among …
  • Noonan Syndrome
    AM Turner. J Paediatr Child Health 50 (10), E14-20. PMID 21771153. - Review
    Noonan syndrome is a common autosomal dominant condition, readily recognisable in childhood. It is characterised by a pattern of typical facial dysmorphism and malformati …
  • Noonan Syndrome
    V Bhambhani et al. Am Fam Physician 89 (1), 37-43. PMID 24444506.
    Noonan syndrome is a common genetic disorder that causes multiple congenital abnormalities and a large number of potential health conditions. Most affected individuals ha …
  • Gain-of-function SOS1 Mutations Cause a Distinctive Form of Noonan Syndrome
    M Tartaglia et al. Nat Genet 39 (1), 75-9. PMID 17143282.
    Noonan syndrome is a developmental disorder characterized by short stature, facial dysmorphia, congenital heart defects and skeletal anomalies. Increased RAS-mitogen-acti …
See all similar articles

Cited by 117 PubMed Central articles

See all "Cited by" articles

Publication types

Feedback